PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

41,824 stories, page 482 of 698

Advanced search
🌍discoverynews.google.comTier 3 · Aggregated media

India’s Life Sciences Proposition Expands from Global Scale to Strategic Innovation

BioPharma APACOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Poland and Taiwan Turn Biotech Dialogue into Partnership at BIO Asia–Taiwan 2026

BioPharma APACOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Hong Kong Makes Its Case as Asia’s Biotech Super-Connector: Capital, Regulation and Scale Converge

BioPharma APACOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBIT forward of Ha Tay Pharmaceutical JSC – HNX:DHT

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to revenue forward of Zhejiang Haisen Pharmaceutical Co., Ltd. Class A – SZSE:001367

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Neuronata-R retains conditional approval in South Korea

The Manila TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

AimedBio expands French clinical trial of ADC ‘BI 4060107’ licensed to Boehringer Ingelheim

더바이오Original source
🌍discoverynews.google.comTier 3 · Aggregated media

NEXEL receives U.S. FDA acceptance of letter of intent for iPSC-derived cardiomyocyte platform ‘Cardiosight-S’

더바이오Original source
🌍discoverynews.google.comTier 3 · Aggregated media

Isomorphic megadeal lifts UK biotech funding to five-year high

European Biotechnology MagazineOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Neuronata-R retains conditional approval in South Korea

Laurel Leader-CallOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Price to earnings forward of Zhejiang Haisen Pharmaceutical Co., Ltd. Class A – SZSE:001367

TradingViewOriginal source
🇪🇸Researchcnic.esTier 2 · Direct publisher

David Sancho recibe el XXII Premio Ciencias de la Salud Fundación Caja Rural Granada

CNIC Spain CardiovascularOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Price to earnings forward of Guizhou Xinbang Pharmaceutical Co., Ltd. Class A – SZSE:002390

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

USDA-FSIS, FDA, and EPA Release MOU Clarifying Interagency Cooperation on Chemical Contaminants in Meat, Poultry, and Egg Products

The National Law ReviewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Veradermics Reports Positive Phase 2 Hair Loss Drug Trial Results

sekbernews.idOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Price to book forward of Tian'an Pharmaceutical Co., Ltd. – OTC:TNPH

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

German biotech company behind COVID-19 vaccine took its first steps with help from the ERDF

European CommissionOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Dimerix Acquires Phase II-Ready DMX-652 to Expand Kidney Disease Pipeline

BioPharma APACOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Latigo preps IPO to fund non-opioid rival to Vertex’s Journax

Fierce BiotechOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

SII & Gates MRI ink pact to manufacture new TB vaccine candidate after successful phase 3 trials

MSNOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Merck Pill Becomes First Oral Option in Growing Class of Cholesterol-Lowering Drugs

MedCity NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

World Pharmaceutical Grade Polyethylene Glycol - Market Analysis, Forecast, Size, Trends and Insights

IndexBoxOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

The Medical Minute: Psychedelics, Cannabis, GLP-1s and Drug Policy Changes

exploreVenangoOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Pakistan, China seal $440m pharma deals to power healthcare, biotech partnership

Pakistan TodayOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Houston’s $6.5B GLP-1 megaproject reveals what's next

ChronOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

The Medical Minute: Psychedelics, Cannabis, GLP-1s and Drug Policy Changes

exploreJeffersonOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

The market for psychedelic drugs to treat mental health conditions gets a big buy signal

CNBCOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Why Did Servier Pay a 68% Premium for Day One Biopharmaceuticals

Kavout | AIOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Price to sales forward of Guizhou Xinbang Pharmaceutical Co., Ltd. Class A – SZSE:002390

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Should West’s 10-Year Global Daikyo Distribution Pact Reshape the GLP-1 Narrative for WST Investors?

simplywall.stOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

The mRESVAX RSV vaccine - Moderna bets on maternal protection in late-stage testing

ad-hoc-news.deOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Did FDA Suspend Mysore Cafe's Licence? Social Media Abuzz With Claims — What We Know

NDTV ProfitOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Weekly Rundown: Biogen pushes anti-tau drug into Phase 3 after endpoint miss

Drug Discovery NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA accepts BMRN's sNDA seeking full approval for Voxzogo

MSNOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Protagonist Therapeutics (PTGX) Rises In Biotech Rally While Valuation Keeps The Debate Open

simplywall.stOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Javelin Biotech and Pfizer Announce Landmark Publication Demonstr

The National Law ReviewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

K-Bio Aims for $30 Billion in Technology Exports Amid Growing Competitiveness

Aju PressOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

AI in drug discovery: From target identification to clinical translation

Drug Discovery NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

The Bull Case For COSMOS Pharmaceutical (TSE:3349) Could Change Following Dividend Shift And 2027 Guidance

simplywall.stOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Rossari Biotech reports strong financial performance for Q1 FY27

Business UpturnOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Rossari Biotech releases Q1 FY27 earnings presentation

Business UpturnOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Rossari Biotech Q1 FY27 Revenue Soars 28% to ₹697 Cr; Margins Dip

WhalesbookOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

SEB Asset Management AB Invests $59.55 Million in Teva Pharmaceutical Industries Ltd. $TEVA

MarketBeatOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Ocugen Targets $259 Million in MENA Licensing Deal for OCU400

MyChesCoOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

K-Bio Aims for $30 Billion in Technology Exports Amid Growing Competitiveness

Aju PressOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Afghan, Uzbek officials discuss expanding cooperation in pharmaceutical sector

Pajhwok Afghan NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Insmed Reports Positive 12-Month TPIP PAH Study Data

t.coOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Moderna Doses First Patient in mRNA-4200 Cancer Trial

t.coOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Pakistan assures Chinese investors of full backing for health care, pharmaceutical investments

Arab NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

104 KATSIS-1: Randomized Phase 3 Trial Evaluating KAT6 Inhibitor PF-07248144 (prifetrastat) Plus Fulvestrant in HR+HER2− Advanced/Metastatic Breast Cancer After Progression on CDK4/6 Inhibitor-Based Therapy

CancerNetworkOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Zhuhai Trinomab Pharmaceutical Co Ltd

ReutersOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Allspring Global Investments Holdings LLC Sells 159,581 Shares of Teva Pharmaceutical Industries Ltd. $TEVA

MarketBeatOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Financial authorities are planning to present principles that should be followed in the media promot..

매일경제Original source
🌍discoverynews.google.comTier 3 · Aggregated media

Evonik Opens New Active Pharmaceutical Ingredient Manufacturing Facility In Indiana

megaproject.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Kenya woos diplomats to back pharmaceutical manufacturing drive

Capitalfm.co.keOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

What Caused uniQure's Dramatic Stock Plunge

Kavout | AIOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Pune Registers Highest Food Safety Complaints Since FDA Portal Launch

curlytales.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

MoPH Holds Meeting in Farah on Enforcement of Anti-Drug Smuggling Law and New Pharmaceutical Regulations

وزارت صحت عامهOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

West Pharmaceutical stock trades steady as recent earnings and innovation investments shape outlook

ad-hoc-news.deOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

India Eyes $2.6 Tn Bioeconomy By 2047, Charts Roadmap To Global Biotech Leadership

BW BusinessworldOriginal source